Lineage Cell Therapeutics (LCTX) Capital Expenditures (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Lineage Cell Therapeutics | 325.89 Mn | 261.99 Mn | 1.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -85.92% |
| Dec 31, 2025 | 677.91% |
| Sep 30, 2025 | -714.29% |
| Jun 30, 2025 | -85.57% |
| Mar 31, 2025 | -73.42% |
| Dec 31, 2024 | 157.04% |
| Sep 30, 2024 | 610.00% |
| Jun 30, 2024 | -47.37% |
| Mar 31, 2024 | -94.29% |
| Dec 31, 2023 | 252.75% |
| Sep 30, 2023 | -270.31% |
| Jun 30, 2023 | 36.17% |
| Mar 31, 2023 | 146.88% |
| Dec 31, 2022 | -240.21% |
| Sep 30, 2022 | 194.85% |
| Jun 30, 2022 | 110.87% |
| Mar 31, 2022 | -68.49% |
| Dec 31, 2021 | 170.37% |
| Sep 30, 2021 | -58.14% |
| Jun 30, 2021 | 1,072.73% |
| Mar 31, 2021 | -89.42% |
| Dec 31, 2020 | 285.71% |
| Sep 30, 2020 | -1,033.33% |
| Jun 30, 2020 | -40.00% |
| Mar 31, 2020 | 42.86% |
| Dec 31, 2019 | -89.86% |
| Sep 30, 2019 | -64.62% |
| Jun 30, 2019 | 15.38% |
| Mar 31, 2019 | 7.64% |
| Dec 31, 2018 | -3.09% |
| Sep 30, 2018 | 315.38% |
| Jun 30, 2018 | -80.30% |
| Mar 31, 2018 | -50.00% |
| Dec 31, 2017 | -13.16% |
| Sep 30, 2017 | 76.06% |
| Jun 30, 2017 | 20.47% |
| Mar 31, 2017 | -44.59% |
| Dec 31, 2016 | -18.49% |
| Sep 30, 2016 | -40.57% |
| Jun 30, 2016 | 37.39% |
| Mar 31, 2016 | -83.71% |
| Dec 31, 2015 | 1,612.44% |
| Sep 30, 2015 | 2,222.22% |
| Jun 30, 2015 | -96.96% |
| Mar 31, 2015 | 2,214.29% |
| Dec 31, 2014 | -102.82% |
| Dec 31, 2013 | -259.24% |
| Sep 30, 2013 | 419.22% |
| Jun 30, 2013 | -51.83% |
| Mar 31, 2013 | 153.55% |
| Dec 31, 2012 | 278.88% |
| Sep 30, 2012 | 40.01% |
| Jun 30, 2012 | -68.37% |
| Mar 31, 2012 | -35.13% |
| Dec 31, 2011 | -25.89% |
| Sep 30, 2011 | 0.16% |
| Jun 30, 2011 | -18.12% |
| Mar 31, 2011 | 444.48% |
| Dec 31, 2010 | 150.72% |